Kaddam Medicos Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.20 M
as on 24-10-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 21.25%
(FY 2023)
- Profit -52.12%
(FY 2023)
- Ebitda -76.02%
(FY 2023)
- Net Worth 8.87%
(FY 2023)
- Total Assets 6.13%
(FY 2023)
About Kaddam Medicos
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmesh Shah, Parmod Anand, Aaushy Sangai, and Three other members serve as directors at the Company.
- CIN/LLPIN
U52609HR2019PTC079518
- Company No.
079518
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Bhiwani, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kaddam Medicos?
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dharmesh Shah | Director | 24-Jan-2020 | Current |
Parmod Anand | Director | 02-Apr-2019 | Current |
Aaushy Sangai | Director | 02-Apr-2019 | Current |
Deepak Bansal | Director | 02-Apr-2019 | Current |
Kavita Devi | Director | 02-Apr-2019 | Current |
Satyaveer Sharma | Director | 03-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Kaddam Medicos.
Kaddam Medicos Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.25% increase. The company also saw a substantial fall in profitability, with a 52.12% decrease in profit. The company's net worth moved up by a moderate rise of 8.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kaddam Medicos?
In 2023, Kaddam Medicos had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kaddam Health Care Private LimitedActive 8 years 5 months
Dharmesh Shah, Parmod Anand and 4 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kaddam Medicos?
Unlock and access historical data on people associated with Kaddam Medicos, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaddam Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaddam Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.